周二盘中，港股晶泰控股（02228）股价突然拉升，涨幅达到5%，引发市场广泛关注。这一涨势背后，是公司在AI制药领域取得的重大突破。
据悉，晶泰控股近期与Dove Tree达成合作协议，有望获得高达58.9亿美元的里程碑付款，创下AI新药研发领域订单规模的新纪录。中信建投证券发布研报称，晶泰控股首次实现盈利，这笔近60亿美元的大单进一步验证了公司在AI制药领域的商业化能力。
除了订单利好，晶泰控股还完成了新一轮26.533亿港元的配售。分析认为，这笔资金将用于稳固财务状况、强化技术实力和扩大市场份额，有利于公司的长远发展。随着AI制药领域的快速发展，晶泰控股作为行业龙头的地位进一步巩固，投资者对其未来前景充满信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.